Staks T - Search Results

1

Pharmacokinetics, dose proportionality, and tolerability of gadobutrol after single intravenous injection in healthy volunteers.

Staks T, Schuhmann-Giampieri G, Frenzel T, Weinmann HJ, Lange L, Platzek J. Staks T, et al. Invest Radiol. 1994 Jul;29(7):709-15. doi: 10.1097/00004424-199407000-00008. Invest Radiol. 1994. PMID: 7960618 Clinical Trial.

2

Dose proportionality of iopromide pharmacokinetics and tolerability after i.v. injection in healthy volunteers.

Krause W, Schuhmann-Giampieri G, Staks T, Kaufmann J. Krause W, et al. Among authors: staks t. Eur J Clin Pharmacol. 1994;46(4):339-43. doi: 10.1007/BF00194402. Eur J Clin Pharmacol. 1994. PMID: 7957519 Clinical Trial.

3

Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging.

Hamm B, Staks T, Mühler A, Bollow M, Taupitz M, Frenzel T, Wolf KJ, Weinmann HJ, Lange L. Hamm B, et al. Among authors: staks t. Radiology. 1995 Jun;195(3):785-92. doi: 10.1148/radiology.195.3.7754011. Radiology. 1995. PMID: 7754011 Clinical Trial.

4

Contrast-enhanced MR imaging of liver and spleen: first experience in humans with a new superparamagnetic iron oxide.

Hamm B, Staks T, Taupitz M, Maibauer R, Speidel A, Huppertz A, Frenzel T, Lawaczeck R, Wolf KJ, Lange L. Hamm B, et al. Among authors: staks t. J Magn Reson Imaging. 1994 Sep-Oct;4(5):659-68. doi: 10.1002/jmri.1880040508. J Magn Reson Imaging. 1994. PMID: 7981510 Clinical Trial.

5

Gadolinium-ethoxybenzyl-DTPA as a hepatobiliary contrast agent for use in MR cholangiography: results of an in vivo phase-I clinical evaluation.

Bollow M, Taupitz M, Hamm B, Staks T, Wolf KJ, Weinmann HJ. Bollow M, et al. Among authors: staks t. Eur Radiol. 1997;7(1):126-32. doi: 10.1007/s003300050125. Eur Radiol. 1997. PMID: 9000414 Clinical Trial.

6

Pharmacokinetics of iotrolan after intravenous injection into healthy volunteers.

Scholz P, Weinmann HJ, Mützel W, Staks T. Scholz P, et al. Among authors: staks t. Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd. 1989;128:211-4. Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd. 1989. PMID: 2568798

7

Pharmacokinetics and pharmacodynamics of cicaprost in healthy volunteers after oral administration of 5 to 20 micrograms.

Hildebrand M, Staks T, Nieuweboer B. Hildebrand M, et al. Among authors: staks t. Eur J Clin Pharmacol. 1990;39(2):149-53. doi: 10.1007/BF00280049. Eur J Clin Pharmacol. 1990. PMID: 2253664

8

Pharmacokinetics of 3H-cicaprost in healthy volunteers.

Hildebrand M, Staks T, Schütt A, Matthes H. Hildebrand M, et al. Among authors: staks t. Prostaglandins. 1989 Feb;37(2):259-73. doi: 10.1016/0090-6980(89)90062-2. Prostaglandins. 1989. PMID: 2657866

9

Oral iloprost in healthy volunteers.

Hildebrand M, Pfeffer M, Mahler M, Staks T, Windt-Hanke F, Schütt A. Hildebrand M, et al. Among authors: staks t. Eicosanoids. 1991;4(3):149-54. Eicosanoids. 1991. PMID: 1722988

10

Pharmacokinetics of levonorgestrel and ethinylestradiol in 14 women during three months of treatment with a tri-step combination oral contraceptive: serum protein binding of levonorgestrel and influence of treatment on free and total testosterone levels in the serum.

Kuhnz W, Staks T, Jütting G. Kuhnz W, et al. Among authors: staks t. Contraception. 1994 Dec;50(6):563-79. doi: 10.1016/0010-7824(94)90014-0. Contraception. 1994. PMID: 7705098 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page